CTMX vs PTC · rev $138.1M vs P/E 48, rev $2.74B
CytomX Therapeutics Inc (CTMX) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
CTMX currently screens at market cap $653.1M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the CTMX and PTC stock pages for the full models.
Not investment advice.